HK1185556A1 - Pharmaceutical agent having long-lasting effect of treating arthritic disorders - Google Patents

Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Info

Publication number
HK1185556A1
HK1185556A1 HK13113014.0A HK13113014A HK1185556A1 HK 1185556 A1 HK1185556 A1 HK 1185556A1 HK 13113014 A HK13113014 A HK 13113014A HK 1185556 A1 HK1185556 A1 HK 1185556A1
Authority
HK
Hong Kong
Prior art keywords
long
pharmaceutical agent
lasting effect
arthritic disorders
treating arthritic
Prior art date
Application number
HK13113014.0A
Other languages
English (en)
Chinese (zh)
Inventor
Kenji Miyamoto
Keiji Yoshioka
Katsuya Takahashi
Original Assignee
生化學工業株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 生化學工業株式會社 filed Critical 生化學工業株式會社
Publication of HK1185556A1 publication Critical patent/HK1185556A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK13113014.0A 2006-12-06 2013-11-21 Pharmaceutical agent having long-lasting effect of treating arthritic disorders HK1185556A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86879806P 2006-12-06 2006-12-06

Publications (1)

Publication Number Publication Date
HK1185556A1 true HK1185556A1 (en) 2014-02-21

Family

ID=39203191

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10102737.2A HK1135923A1 (en) 2006-12-06 2010-03-16 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
HK13113014.0A HK1185556A1 (en) 2006-12-06 2013-11-21 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK10102737.2A HK1135923A1 (en) 2006-12-06 2010-03-16 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Country Status (10)

Country Link
US (3) US8889652B2 (xx)
EP (3) EP2910248A1 (xx)
JP (3) JP5291621B2 (xx)
KR (1) KR101460815B1 (xx)
CN (2) CN103356694B (xx)
AU (1) AU2007328871B2 (xx)
CA (1) CA2672002C (xx)
HK (2) HK1135923A1 (xx)
TW (2) TWI419697B (xx)
WO (1) WO2008069348A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008069348A1 (en) 2006-12-06 2008-06-12 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JO3008B1 (ar) * 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
ITTO20110428A1 (it) * 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
CA2917715A1 (en) 2013-07-08 2015-01-15 Denka Company Limited Core-shell crosslinked hyaluronic acid gel particles, production method for same, and medical material
US20150133561A1 (en) * 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
WO2016002983A1 (ko) * 2014-06-30 2016-01-07 (주)메디톡스 가교된 히알루론난을 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법
KR102357341B1 (ko) * 2014-11-06 2022-02-03 주식회사 엘지생활건강 숙지황 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용
KR101521411B1 (ko) * 2015-02-05 2015-05-19 박재우 뼈 및 연골을 포함한 관절질환 치료용 조성물 및 이의 제조방법
KR101637883B1 (ko) * 2015-09-30 2016-07-21 선바이오(주) 폴리에틸렌글리콜 수화젤 주사제
KR101895950B1 (ko) * 2015-12-18 2018-09-06 (주)한국비엠아이 골관절염 치료를 위한 친수화된 설파살라진 및 히알루론산을 포함하는 조성물 및 이의제조방법
TWI727151B (zh) 2017-03-14 2021-05-11 日商生化學工業股份有限公司 關節疾患處置用組成物及含有該組成物的套組
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送
CN115444840B (zh) * 2022-09-15 2023-08-25 四川大学 一种前药、两性离子水凝胶及其制备方法、应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210034A (ja) 1985-03-15 1986-09-18 Seikagaku Kogyo Co Ltd 関節症治療剤
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
JPH0574571A (ja) 1990-12-25 1993-03-26 Ricoh Co Ltd 電界発光素子
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
JP3343181B2 (ja) * 1995-09-20 2002-11-11 生化学工業株式会社 桂皮酸誘導体
US6025444A (en) 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
JP3955107B2 (ja) * 1995-05-01 2007-08-08 生化学工業株式会社 架橋多糖の製造法
HU224697B1 (en) * 1995-11-15 2006-01-30 Seikagaku Kogyo Co Ltd Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
EP0939086B1 (en) 1998-02-27 2004-03-10 Stichting Hippomedics Process for producing crosslinked hyaluronic acid
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
CN1259343C (zh) 2000-02-03 2006-06-14 电气化学工业株式会社 透明质酸凝胶、其制造方法以及含有它的医用材料
DE60117502T2 (de) * 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
JP4172176B2 (ja) * 2000-12-19 2008-10-29 生化学工業株式会社 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料
JP4990446B2 (ja) 2001-05-28 2012-08-01 電気化学工業株式会社 関節症治療用注入剤
JP4958368B2 (ja) 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸
EP1794192B1 (en) 2004-09-15 2016-05-04 Seikagaku Corporation Photoreactive polysaccharide, photocrosslinked polysaccharide products, the method of making them and medical materials made therefrom
CA2590159C (en) 2004-12-30 2011-07-12 Genzyme Corporation Regimens for intra-articular viscosupplementation
JP5147396B2 (ja) * 2005-07-06 2013-02-20 生化学工業株式会社 薬剤導入光架橋ヒアルロン酸誘導体ゲル
CN103120701B (zh) 2005-10-12 2014-11-05 生化学工业株式会社 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途
WO2008069348A1 (en) 2006-12-06 2008-06-12 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم

Also Published As

Publication number Publication date
TW201414479A (zh) 2014-04-16
CN103356694A (zh) 2013-10-23
AU2007328871A1 (en) 2008-06-12
TWI419697B (zh) 2013-12-21
TWI528964B (zh) 2016-04-11
AU2007328871B2 (en) 2013-11-21
CA2672002A1 (en) 2008-06-12
EP2910248A1 (en) 2015-08-26
WO2008069348A9 (en) 2009-08-20
US20150283169A1 (en) 2015-10-08
CN101573123A (zh) 2009-11-04
EP2386306A1 (en) 2011-11-16
JP2010511596A (ja) 2010-04-15
TW200831113A (en) 2008-08-01
CN101573123B (zh) 2013-06-05
US20150094280A1 (en) 2015-04-02
KR101460815B1 (ko) 2014-11-12
CA2672002C (en) 2015-06-02
US20110053885A1 (en) 2011-03-03
US8889652B2 (en) 2014-11-18
US9301972B2 (en) 2016-04-05
US9616087B2 (en) 2017-04-11
JP5291621B2 (ja) 2013-09-18
WO2008069348A1 (en) 2008-06-12
CN103356694B (zh) 2015-09-02
JP5889976B2 (ja) 2016-03-22
JP2013209417A (ja) 2013-10-10
HK1135923A1 (en) 2010-06-18
JP2014237704A (ja) 2014-12-18
JP5600192B2 (ja) 2014-10-01
EP2094280A1 (en) 2009-09-02
KR20090087496A (ko) 2009-08-17

Similar Documents

Publication Publication Date Title
HK1185556A1 (en) Pharmaceutical agent having long-lasting effect of treating arthritic disorders
EP2107909A4 (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC DISORDERS
HK1212598A1 (zh) 用於預防口腔疾病的組合物及方法
IL231463A (en) Carboxamide compounds and their use in drug preparation
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
HK1134679A1 (zh) 用於治療感染的組合物和方法
EP2099449A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
ZA201000991B (en) Pharmaceutical compositions and methods of treating dry eye disorders
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
EP1996218A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
EP2012807A4 (en) PHARMACEUTICAL COMPOSITION FROM AN ENTEROSORBEN AND PREBIOTIKA, DOSAGE FORMS AND METHOD FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP2119436A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES
HK1247943A1 (zh) 發育相關疾病的治療
EP2217238A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA
HRP20130791T1 (xx) Farmaceutski pripravci za lijeäśenje kapilarne arteriopatije
EP2077838A4 (en) METHODS FOR TREATING A-RELATED DISORDERS AND COMPOSITIONS THEREFOR
EP2004216A4 (en) AGENT FOR THE TREATMENT OF HORMONO-DEPENDENT DISORDERS AND USES THEREOF
PL1847256T3 (pl) Kompozycje przeciwbakteryjne do leczenia infekcji górnych i dolnych dróg oddechowych
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
EP2231146A4 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
EP2096927A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF TREATING WITH CAPSIANOSIDE COMPOUNDS
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221202